Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This pilot study is designed to determine the feasibility of conducting a randomized clinical
trial comparing fondaparinux sodium (Arixtra) once daily with enoxaparin (Lovenox®) twice
daily with respect to preventing deep vein thrombosis (DVT) and pulmonary embolism (PE) after
bariatric surgery in obese patients.